Comparison Chart Karyopharm Therapeutics Inc. Boerse Muenchen
Stocks
25K0
US48576U2050
Pharmaceuticals
|
Real-time
Boerse Muenchen
03:13:11 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 0.6200 EUR | +5.98% |
|
-46.82% | - |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Biopharmaceuticals | +5.98% | -46.82% | - | - | - | 14.74M |
-
|
-
|
-
|
Select your edition
All financial news and data tailored to specific country editions
